Waldemar Halota
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, Liver Diseases and Immunity
Most-Cited Works
- → Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡(2010)980 cited
- → Entecavir Treatment for Up to 5 Years in Patients With Hepatitis B E Antigen–Positive Chronic Hepatitis B(2010)586 cited
- → A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel(2011)406 cited
- → The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm – volume 2(2015)124 cited
- → Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases.(2003)107 cited
- → Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study(2016)99 cited
- → Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial(2017)96 cited
- → Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients(2002)94 cited
- → Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 2(2015)93 cited
- → Recommendations for the treatment of hepatitis C in 2017(2017)86 cited